EUVIMEDEUVIMED entdecken
Open Access

Genetic dissection of Huntington’s disease modification by variation at RRM2B

Kiuk Lee, Baehyun Shin, Mingyu Kim, Seong Won Lee, Young Mi Oh, Kyung-Hee Kim, Andrew Jiang, Kwanyoung Ko, Tammy Gillis, Diane Lucente, Ramee Lee, Seung Kwak und 6 weitere

Human Molecular Genetics · 2025

DOI: 10.1093/hmg/ddaf150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2025. Verfasst von Kiuk Lee und 17 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Neurogenetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, United States. Hauptthemen laut MEDLINE: Huntington Disease, Ribonucleoside Diphosphate Reductase. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, National Institutes of Health National Institute of Neurological Disorders and Stroke, CHDI Foundation Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Huntington’s disease (HD) is driven by somatic expansion of the HTT CAG repeat, with onset modified by genetic factors. One such modifier, 8AM1, maps to chromosome 8 near RRM2B, a gene not directly involved in the machinery that lengthens the repeat. To investigate this locus, we performed capture sequencing and identified variants at both the 5′ and 3′ ends of RRM2B with expected minor allele frequencies. A polymorphic frameshift variant (rs1037699) in an alternate exon 1 disrupts expression of a previously uncharacterized RRM2B isoform 2, but not isoform 1. Functional analyses in RRM2B knock-out cells and 8AM1 heterozygous LCLs suggest that isoform 2 may function at mitochondria. Several 3′ variants, including a 21 bp 3’UTR deletion (rs200678743) and peak tag-SNV (rs79136984), act as cis expression quantitative trait loci. Analysis of HD onset data (n = 12,982) revealed that 5′ and 3′ variants contribute independently to the 8AM1 modifier effect, with full impact observed only in the absence of the frameshift variant. Knockdown of both isoforms increased neurodegeneration in HD neurons derived from pre-symptomatic patient fibroblasts, supporting an intersection of RRM2B biology and HD pathogenesis. We conclude that the 8AM1 haplotype, present in ~ 14% of Europeans, modifies RRM2B expression in a cell- and context-dependent manner, thereby accelerating HD onset in mutation carriers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseRibonucleoside Diphosphate ReductaseHumansProtein IsoformsHuntingtin ProteinFrameshift MutationQuantitative Trait LociNeuronsPolymorphism, Single NucleotideGenetic Predisposition to DiseaseTrinucleotide Repeat ExpansionGene FrequencyRibonucleotide ReductasesCell Cycle Proteins

Stichwörter der Autor:innen

Expression quantitative trait lociGenetic ModifierNeurodegenerationmitochondrial DNA maintenanceribonucleotide reductase

Substanzen

RRM2B protein, humanProtein IsoformsRibonucleoside Diphosphate ReductaseHuntingtin ProteinHTT protein, humanRibonucleotide ReductasesCell Cycle Proteins

Autor:innen und Institutionen

  • Molecular Neurogenetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, United States.
  • Department of Neurology, Harvard Medical School, 220 Longwood Avenue, Boston, MA 02114, United States.
  • Department of Biomedical Sciences, Mercer University School of Medicine, 1633 1st Avenue, Columbus, GA 31901, United States.
  • CHDI Management/CHDI Foundation Inc., 155 Village Boulevard, Princeton, NJ 08540, United States.
  • Department of Developmental Biology, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, United States.
  • Medical and Population Genetics Program, The Broad Institute of M.I.T. and Harvard, 415 Main Street, Cambridge, MA 02142, United States.

ORCID-Profile: Ihn Sik Seong

Förderung

  • NINDS NIH HHS
  • National Institutes of Health National Institute of Neurological Disorders and Stroke
  • CHDI Foundation Inc.

Zitieren

APA

Lee, K., Shin, B., Kim, M., Lee, S. W., Oh, Y. M., Kim, K. H., Jiang, A., Ko, K., Gillis, T., Lucente, D., Lee, R., Kwak, S., Lee, J. M., Wheeler, V. C., Yoo, A. S., Gusella, J. F., MacDonald, M. E., & Seong, I. S. (2025). Genetic dissection of Huntington’s disease modification by variation at RRM2B. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddaf150

Vancouver

Lee K, Shin B, Kim M, Lee SW, Oh YM, Kim KH, et al. Genetic dissection of Huntington’s disease modification by variation at RRM2B. Human Molecular Genetics. 2025. doi:10.1093/hmg/ddaf150

BibTeX
@article{Lee2025,
  author = {Lee, Kiuk and Shin, Baehyun and Kim, Mingyu and Lee, Seong Won and Oh, Young Mi and Kim, Kyung-Hee and Jiang, Andrew and Ko, Kwanyoung and Gillis, Tammy and Lucente, Diane and Lee, Ramee and Kwak, Seung and Lee, Jong-Min and Wheeler, Vanessa C and Yoo, Andrew S and Gusella, James F and MacDonald, Marcy E and Seong, Ihn Sik},
  title = {Genetic dissection of Huntington’s disease modification by variation at RRM2B},
  journal = {Human Molecular Genetics},
  year = {2025},
  doi = {10.1093/hmg/ddaf150}
}
Kostenlos starten →